Fabhalta 200 MG
Ended Awarded
- Contract number
- 36C24525N0929
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,838
Award facts
- Contract value 100% obligated
- $33,838.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Novartis Pharmaceuticals Corporation, a large foreign-owned pharmaceutical manufacturer, for the delivery of the drug Fabhalta 200 mg. The contract, valued at $33,838.23, is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of August 28, 2025 and does not utilize a small business set-aside designation. Novartis holds a $5.4 billion FSS contract for pharmaceuticals and drugs, as well as a $21.5 million Blanket Purchase Agreement (BPA) specifically for the CAR T-cell therapy Kymriah, which supports the procurement of specialized medical treatments for the VA's medical programs.
Quick answers
Who was awarded contract 36C24525N0929?
36C24525N0929 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 22, 2025.
How much is contract 36C24525N0929 worth?
The government has obligated $33,838 on 36C24525N0929.
Is contract 36C24525N0929 an order under another contract?
Yes. 36C24525N0929 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0929 competed?
The extent of competition for 36C24525N0929 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award